Kentucky Doc Spring 2014 | Page 10

10 doc • Spring 2014 Kentucky Promising Glaucoma Treatments On The Horizon By Doris Settles, Staff Writer In the early 1940s, my grandmother was diagnosed with glaucoma. Essentially, the doctor explained that her vision would progressively worsen as she lost more peripheral vision; no treatment was recommended. Today, the patient diagnosed with glaucoma looks forward to aggressive treatment in a wide variety of options with even more in the pipeline. Historically, topical treatments for glaucoma have been available since the 1860s, when a British physician noticed the potential eye pressure benefits of the calabar bean. There are now four common classes of eye drops routinely prescribed for glaucoma patients, some in multiple formulations, providing physicians with a substantial armamentarium of treatments. Current glaucoma medications reduce intraocular pressure (IOP) by either reducing the production of fluid in the eye, or by increasing its outflow. Prostaglandins, which increase outflow, are now the most prescribed glaucoma treatment worldwide. A new experimental medication for glaucoma, BOL 303259-X (Bausch and Lomb), seems to lower intraocular pressure as effectively and safely as the gold standard, latanoprost, and might be more potent, say investigators. Dr. Daniel Moore, Assistant Professor of Opthalmology and Visual Sciences at the University of Kentucky, explains, “This is a slightly modified target of the ‘newest’ class of medications, the prostaglandins (on the market since the mid-1990s).” Currently undergoing a phase III trial, early results suggest it may be as efficacious as current prostaglandins if not slightly superior. But Moore sees more on the horizon. “A new class of medications — ‘Rho kinase inhibitors’ — are currently in clinical trials and are expected to become available in the next five to 10 years. Early results suggest these medications are equally effective as available agents.” Duke University’s semiindependent pharmaceutical company has one of this new class of drugs starting Phase III of clinical investigation. Cardinal Hill “Cardinal Hill Home Care is an extension of the quality care offered by Cardinal Hill Rehabilitation Hospital” Serving Fayette, Franklin, Jessamine, Madison and Woodford Counties (859) 367-7148